Maiken Keson-brookes - Net Worth and Insider Trading
Maiken Keson-brookes Net Worth
The estimated net worth of Maiken Keson-brookes is at least $305 dollars as of 2024-06-06. Maiken Keson-brookes is the CLO & Corp. Secretary of Rubius Therapeutics Inc and owns about 5,343 shares of Rubius Therapeutics Inc (RUBY) stock worth over $305. Details can be seen in Maiken Keson-brookes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maiken Keson-brookes has not made any transactions after 2022-02-01 and currently still holds the listed stock(s).
Transaction Summary of Maiken Keson-brookes
Maiken Keson-brookes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Maiken Keson-brookes owns 2 companies in total, including Rubius Therapeutics Inc (RUBY) , and uniQure NV (QURE) .
Click here to see the complete history of Maiken Keson-brookes’s form 4 insider trades.
Insider Ownership Summary of Maiken Keson-brookes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2022-02-01 | CLO & Corp. Secretary |
| QURE | uniQure NV | 2017-01-01 | General Counsel |
Maiken Keson-brookes Latest Holdings Summary
Maiken Keson-brookes currently owns a total of 1 stock. Maiken Keson-brookes owns 5,343 shares of Rubius Therapeutics Inc (RUBY) as of February 1, 2022, with a value of $305.
Latest Holdings of Maiken Keson-brookes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RUBY | Rubius Therapeutics Inc | 2022-02-01 | 5,343 | 0.06 | 305 |
Holding Weightings of Maiken Keson-brookes
Maiken Keson-brookes Form 4 Trading Tracker
According to the SEC Form 4 filings, Maiken Keson-brookes has made a total of 2 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Rubius Therapeutics Inc is the sale of 2,732 shares on February 1, 2022, which brought Maiken Keson-brookes around $17,949.
Insider Trading History of Maiken Keson-brookes
- 1
Maiken Keson-brookes Trading Performance
Maiken Keson-brookes Ownership Network
Maiken Keson-brookes Owned Company Details
What does Rubius Therapeutics Inc do?
Who are the key executives at Rubius Therapeutics Inc?
Maiken Keson-brookes is the CLO & Corp. Secretary of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .
Rubius Therapeutics Inc (RUBY) Insider Trades Summary
Over the past 18 months, Maiken Keson-brookes made no insider transaction in Rubius Therapeutics Inc (RUBY). Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .
In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.
Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rubius Therapeutics Inc Insider Transactions
Maiken Keson-brookes Mailing Address
Above is the net worth, insider trading, and ownership report for Maiken Keson-brookes. You might contact Maiken Keson-brookes via mailing address: 35 Oak Hill Road, Fayville Ma 01745.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
